Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects

Clinical Pharmacology and Therapeutics

Volumn 66, Issue 1, 1999, Pages 76-84

  Rossat, Julien ^a   Maillard, Marc ^a   Nussberger, Jürg ^a   Brunner, Hans R ^a   Burnier, Michel ^a,b  

^a Department of Nephrology/Hypertension   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; NAPROXEN;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIURESIS; DOUBLE BLIND PROCEDURE; ELECTROLYTE EXCRETION; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN EXPERIMENT; KIDNEY BLOOD FLOW; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM DEPLETION; SODIUM EXCRETION; SODIUM RETENTION; URINE VOLUME;

ADULT; BLOOD PRESSURE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; HUMANS; ISOENZYMES; KIDNEY; LITHIUM; MALE; MEMBRANE PROTEINS; NAPROXEN; POTASSIUM; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; REFERENCE VALUES; SODIUM; SULFONAMIDES; VOLUNTARY WORKERS;

EID: 0032777567     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(99)70056-1     Document Type: Article

References (32)

1. 1. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB. Arachidonic acid metabolism. Annu Rev Biochem 1986;55:69-102.
2. 2. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Hershman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991;266:12866-72.
3. 3. Xie W, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991;88:2692-6.
4. 4. Hla T, Nielson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992;89:7384-8.
5. 5. O'Banion MK, Sadowski HB, Winn V, Young DA. A scrum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 1991;266:23261-7.
6. 6. Masferrer JL, Seibert K, Zweifel B, Needleman P. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci USA 1992; 89:3917-21.
7. 7. Fu J, Masferrer J, Seibert K, Raz A, Needleman P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 1990;265:16737-40.
8. 8. Masferrer JL, Zweifel BS, Seibert K, Needleman P. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest 1990;86:1375-9.
9. 9. Walker L, Frölich JC. Renal prostaglandins and leukotrienes. Rev Physiol Biochem Pharmacol 1987;107: 1-72.
10. 10. Kömhoff M, Gröne HJ, Klein T, Seyberth HW, Nüsing RM. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol 1997;272(4 pt 2):F460-8.
11. 11. Vio CP, Cespedes C, Gallardo P, Masferrer JL. Renal identification of cyclooxygenase-2 in a subset of thick ascending limb cells. Hypertension 1997;30(pt 2):687-92.
12. 12. Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest 1994;94:2504-10.
13. 13. Harrison HE. A modification of the diphenylamine method for the determination of inulin. Proc Soc Exp Biol Med 1942;49:111-4.
14. 14. Friedman SM, Policy JR, Friedman CL. The clearance of inulin and sodium p-aminohippurate in the rat. Am J Physiol 1947;150:340-52.
15. 15. Magnin JL, Decosterd LA, Centeno C, Burnier M, Diezi J, Biollaz J. Determination of trace lithium in biological fluids using graphite furnace atomic absorption spectrophotometry: variability of urine matrices circumvented by cation exchange solid phase extraction. Pharm Acta Helv 1996;71:237-46.
16. 16. Nussberger J, Fasanella d'Amore T, Porchet M, Waeber B, Brunner DB, Brunner HR, et al. Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers. J Cardiovasc Pharmacol 1987;9:39-44.
17. 17. Penning TD, Talley JJ, Bertenshaw SR, Carter JS, Collins PW, Docter S, et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluorometnyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). J Med Chem 1997;40:1347-65.
18. 18. Zhang Y, Shaffer A, Portanova J, Seibert K, Isakson PC. Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production. J Pharmacol ExpTher 1997;283:1069-75.
19. 19 Riendeau D, Charleson S, Cromlish W, Mancini JA, Wong E, Guay J. Comparison of the cyclooxygenase-I inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. Can J Physiol Pharmacol 1997;75:1088-95.
20. 20. Lipsky PE, Isakson PC. Outcome of specific COX-2 inhibition in rheumatoid arthritis [review]. J Rheumatol 1997; 24(suppl49):9-14.
21. 21. Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, et al. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA 1994; 91:3228-32.
22. 22. Jensen BL, Kurtz A. Differential regulation of renal cyclooxygenases mRNA by dietary salt intake. Kidney Int 1997;52:1242-9.
23. 23. Kramer HJ, Stinnesbeck B, Klautke G, Kipnowski J, Klingmueller D, Glaentzer K, et al. Interaction of renal prostaglandins with the renin-angiotensin and renal adrenergic nervous systems in healthy subjects during dietary changes in sodium intake. Clin Sci 1985;68:387-93.
24. 24. Donker AJ, Arisz L, Brentjens JR, Van Der Hem GH, Hollemans HJ. The effect of indomethacin on kidney function and plasma renin activity in man. Nephron 1976;17:288-96.
25. 25. Sedor JR, Williams SL, Chremos AN, Johnston CL, Dunn MJ. Effects of sulindac and indomethacin on renal prostaglandin synthesis. Clin Pharmacol Ther 1984;36: 85-91.
26. 26. Passmore AP, Copeland S, Johnston GD. A comparison of the effects of ibuprofen and indomethacin upon renal haemodynamics and electrolyte excretion in the presence and absence of frusemide. Br J Clin Pharmacol 1989;27: 483-90.
27. 27. Stokes JB. Effect of prostaglandin E on chloride transport across the rabbit thick ascending limb of Henle: selective inhibition of the medullary portion. J Clin Invest 1979;64:495-502.
28. 28. Ganguli M, Tobian L, Azar S, O'Donnel M. Evidence that prostaglandin synthesis inhibitors increase the concentration of sodium and chloride in the renal medulla. Circ Res 1977;40(suppl 1):135-9.
29. 29. Brown J, Dollery C, Vades G. Interaction of non-steroidal anti-inflammatory drugs with antihypertensive and diuretic agens: control of vascular reactivity by endogenous prostanoids. Am J Med 1986;81(suppl 2B):43-57.
30. 30. Rabelink AJ, Koomans HA, Boer WH, Dorhout Mees EJ, van Rijn HJM. Indomethacin increases renal lithium reabsorption in man. Nephrol Dial Transplant 1989;4:27-31.
31. 31. Harding P, Sigmon DH, Alfie ME, Huang PL, Fishman MC, Beierwaltes WH, et al. Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet. Hypertension 1997;29(part 2):297-302.
32. 32. Burnier M, Pechère-Bertschi A, Nussberger J, Waeber B, Brunner HR. Studies of the renal effects of angiotensin II receptor blockade: the confounding factor of acute water loading on the action of vasoactive systems. Am J Kidney Dis 1995;26:108-15.